Weakening the negative biological activities of recombinant human tumor necrosis factor (hTNF) via immunization with the V91D hTNF derivative induces potent neutralizing antibodies against hTNF in vivo
Haruka Yamamoto-Kosugi, Hidenori Ando, Mako Fukumoto, Shoichiro Fukuda, Shunji Abe, Shingo Kobayashi et al. Weakening the negative biological activities of recombinant human tumor necrosis factor (hTNF) via immunization with the V91D hTNF derivative induces potent neutralizing antibodies against hTNF in vivo. // Journal of Autoimmunity. – DOI: 10.1016/j.jaut.2026.103655. – URL: https://www.sciencedirect.com/science/article/pii/S0896841126001332?dgcid=rss_sd_all
Haruka Yamamoto-Kosugi, Hidenori Ando, Mako Fukumoto, Shoichiro Fukuda, Shunji Abe, Shingo Kobayashi, Haruka Takata, Yasukazu Omoto, & Tatsuhiro Ishida Weakening the negative biological activities of recombinant human tumor necrosis factor (hTNF) via immunization with the V91D hTNF derivative induces potent neutralizing antibodies against hTNF in vivo. Journal of Autoimmunity. https://doi.org/10.1016/j.jaut.2026.103655
Haruka Yamamoto-Kosugi, et al. “Weakening the negative biological activities of recombinant human tumor necrosis factor (hTNF) via immunization with the V91D hTNF derivative induces potent neutralizing antibodies against hTNF in vivo.” Journal of Autoimmunity. doi:10.1016/j.jaut.2026.103655.
@article{YamamotoKosugi,
title = {Weakening the negative biological activities of recombinant human tumor necrosis factor (hTNF) via immunization with the V91D hTNF derivative induces potent neutralizing antibodies against hTNF in vivo},
author = {Yamamoto-Kosugi, Haruka and Ando, Hidenori and Fukumoto, Mako and Fukuda, Shoichiro and Abe, Shunji and Kobayashi, Shingo and Takata, Haruka and Omoto, Yasukazu and Ishida, Tatsuhiro},
journal = {Journal of Autoimmunity},
doi = {10.1016/j.jaut.2026.103655},
url = {https://www.sciencedirect.com/science/article/pii/S0896841126001332?dgcid=rss_sd_all}
}
Mesenchymal stem cells (MSCs) have emerged as promising therapeutic agents in regenerative medicine, with their therapeutic effects increasingly attributed to intercellular communication and microenvironmental regulation rather than...
Background Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. Methods We analyzed GEO...
Background Lung cancer is one of the leading causes of cancer-related mortality worldwide. Understanding the molecular mechanisms underlying lung cancer progression is critical for identifying novel therapeutic targets. This study...